📰 Zero Life Sciences News
Page 5 - Zero Life Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Zero Life Sciences. Real-time updates on events, politics, business and more.
May 13, 2022
Press release content from Accesswire. The AP news staff was not involved in its creation.
April 22, 2022
Navidea Biopharmaceuticals (NYSE:NAVB – Get Rating) and StageZero Life Sciences (OTCMKTS:SZLSF – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, profitability, risk, dividends, institutional ownership and valuation. Risk & Volatility Navidea Biopharmaceuticals has a beta […]
April 14, 2022
StageZero Life Sciences (OTCMKTS:GNWSF – Get Rating) and Alpha Teknova (NASDAQ:TKNO – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, institutional ownership, analyst recommendations and earnings. Profitability This table compares StageZero Life Sciences and […]
April 13, 2022
StageZero Life Sciences Ltd. (OTCMKTS:SZLSF – Get Rating) was the target of a large drop in short interest in the month of March. As of March 31st, there was short interest totalling 12,800 shares, a drop of 69.6% from the March 15th total of 42,100 shares. Based on an average trading volume of 6,400 shares, […]
April 7, 2022
TORONTO - Some of the most active companies traded Wednesday on the Toronto Stock Exchange:...
April 6, 2022
TORONTO, ON / ACCESSWIRE / April 6, 2022 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS), a vertically-integrated healthcare company devoted to improving the early detection and management
April 6, 2022
TORONTO - Some of the most active companies traded Wednesday on the Toronto Stock Exchange:
April 1, 2022
STAGEZERO LIFE SCIENCES LTD. MANAGEMENT'S DISCUSSION AND ANALYSIS. The following discussion and analysis provides management's perspective on the financial position and results of operations of StageZero Life Sciences Ltd. on a consolidated basis for the year and three-month periods ended December 31, 2021 and 2020, and it should be read in...
March 31, 2022
Innovative program helps identify and address the early warning signs of cancer and chronic diseaseTORONTO, ON / ACCESSWIRE / March 31, 2022 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero"
March 29, 2022
TORONTO, ON / ACCESSWIRE / March 29, 2022 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS) today announced that it will release its fourth quarter and year end 2021 operational results